查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511923

胜任细胞市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区和细分市场预测，2024-2030 年

Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

胜任细胞市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球胜任细胞市场规模将达35.9亿美元，2024年至2030年复合年增长率为8.10%。

生物製药研究的增加、基因编辑技术的进步以及合成生物学领域的扩展预计将推动市场成长。此外，生物技术和製药产业严重依赖胜任细胞来生产重组蛋白、酵素和疫苗。治疗、研究和工业应用对这些产品的需求不断增长，推动了对胜任细胞的需求。

COVID-19 大流行大大促进了胜任细胞市场的发展。感受态细胞的需求量很大，因为它们对于分子克隆、基因工程和重组蛋白製造等任务至关重要，并且在疫苗製造、诊断测试和治疗研究中发挥关键作用。鑑于生产疫苗和治疗 COVID-19 的迫切需要，生物技术和製药公司正在努力改进克隆过程。这些因素正在推动市场成长，预计在预测期内将出现指数级增长。

此外，预计细胞製备技术的进步将进一步推动对感受态细胞的需求。感受态细胞製备和转化效率的技术进步对感受态细胞的性能和可靠性产生了重大影响，导致研究人员和工业用户的需求不断增加。此外，基因修饰和压力反应途径的开发进一步提高了转化的可实现性，提供了针对特定应用的解决方案，并提高了胜任细胞在各个领域的效用。预计这些因素将在预测期内推动市场成长。

然而，生产和维护高效胜任细胞的高成本可能会限制其使用，特别是对于预算有限的小型研究机构和新兴企业而言。预计这将影响胜任细胞在某些市场的采用率。此外，製备胜任细胞并成功转化它们的过程在技术上可能很复杂，并且需要专门的知识和设备。因此，它将阻碍预测期内的市场成长。

胜任细胞市场报告亮点

  • 化学胜任细胞广泛应用于重组DNA技术和分子生物学领域，2023年占最大市场占有率，为43.62%。另一方面，预计电感受态细胞在预测期内将以最快的复合年增长率成长。
  • 克隆细分市场预计将在 2023 年占据应用细分市场占有率。然而，由于各种工业和学术应用所需的重组蛋白和酶的需求不断增长，预计蛋白质表达领域在预测期内将以 9.04% 的复合年增长率增长最快。
  • 由于药物发现和药物开发对感受态细胞的需求不断增长，以及满足监管标准所需的多项定性测试，製药和生物技术公司细分市场将在 2023 年占据最大份额。
  • 由于生物技术、医学和治疗学的强大研发以及政府的大量资助等因素，北美地区以 34.13% 的份额占据市场主导地位。预计亚太地区在预测期内将以最快的复合年增长率成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章胜任细胞市场变因、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望。
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 胜任细胞市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章胜任细胞市场：按类型估计和趋势分析

  • 细分仪表板
  • 全球胜任细胞市场：类型变异分析
  • 2018-2030年全球胜任细胞市场规模及趋势分析（按类型）
  • 化学胜任细胞
  • 胜任细胞
  • 超胜任细胞

第五章胜任细胞市场：依应用估算与趋势分析

  • 细分仪表板
  • 全球胜任细胞市场：应用变化分析
  • 2018-2030 年全球胜任细胞市场规模与趋势分析（按应用）
  • 复製
  • 蛋白质表现
  • 诱变
  • 其他的

第六章胜任细胞市场：最终用途的估计与趋势分析

  • 细分仪表板
  • 全球胜任细胞市场：最终用途变化分析
  • 2018-2030 年全球胜任细胞市场规模与趋势分析（依最终用途）
  • 製药和生物技术公司
  • 学术研究所
  • 其他的

第七章胜任细胞市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 2018-2030年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018年至2030年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018年至2030年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Takara Bio Inc.
    • New England Biolabs（UK）Ltd.
    • Promega Corporation
    • Bio-Rad Laboratories
    • Roche Applied Science
    • Qiagen
    • SGI-DNA（Synthetic Genomics, Inc.）
Product Code: GVR-4-68040-310-3

Competent Cells Market Growth & Trends:

The global competent cells market size is anticipated to reach USD 3.59 billion by 2030, exhibiting a CAGR of 8.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing biopharmaceutical research, advancements in gene editing technologies, and the expanding field of synthetic biology is expected to propel market growth. Moreover, the biotechnology and pharmaceutical industries depend heavily on competent cells for the production of recombinant proteins, enzymes, and vaccines. The growing need for these products in medical treatments, research, and industrial applications fuels the demand for competent cells.

The COVID-19 pandemic has significantly boosted the market for competent cells, as companies increased their research and development efforts to address immediate health and scientific challenges. Competent cells, vital for tasks like molecular cloning, genetic engineering, and making recombinant proteins, have been in higher demand due to their key role in creating vaccines, diagnostic tests, and therapeutic research. The urgent need for vaccine manufacturing and treatments for COVID-19 has driven biotech and pharmaceutical companies to improve their cloning processes. These factors have impelled the growth of the market and are anticipated to propel exponentially over the forecast period.

In addition, technological advancements in cell preparation are projected to further propel the demand for competent cells. Technological advancements in the preparation and transformation efficiency of competent cells have significantly impacted the performance and reliability of competent cells, thus increasing the demand for researchers and industrial users. Additionally, genetic modifications and stress response pathway developments have further boosted transformation accomplishment, providing tailored solutions for specific applications, and advancing the utility of competent cells in various fields. These factors are thus projected to impel the growth of the market over the forecast period.

However, the high cost of producing and maintaining high-efficiency competent cells is considerable, which may limit their accessibility, especially for smaller research institutions and startups with limited budgets. This is anticipated to affect the adoption rate of competent cells in certain markets. Moreover, the process of preparing competent cells and accomplishing successful transformations could be technically complex and involve specialized knowledge and equipment. Thereby, hampering the growth of the market over the forecast period.

Competent Cells Market Report Highlights:

  • The chemically competent cells segment held the largest market share of 43.62% in 2023 due to their wide use in the field of recombinant DNA technology, and molecular biology. On the other hand, electrocompetent cells are anticipated to grow at the fastest CAGR over the forecast period.
  • In 2023, the cloning segment is anticipated to dominate the market share for the application segment. However, the protein expression segment is expected to grow at the fastest CAGR of 9.04% over the forecast period driven by the increasing demand for recombinant proteins and enzymes required in various industrial and academic applications.
  • The pharmaceutical & biotechnology companies segment dominated the end-use segment with the largest share in 2023 due to the rising demand for competent cells for drug discovery and development, along with the few qualitative tests required to fulfill the regulatory standards.
  • The North America region dominated the market with a share of 34.13% owing to factors such as strong R&D in biotechnology, medicine, and therapeutics, along with substantial government funding. Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Competent Cells Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing demand for recombinant proteins and antibodies
      • 3.2.1.2. Growing biotechnology and pharmaceutical industries
      • 3.2.1.3. Increasing research and development activities
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Costs of Competent Cells
  • 3.3. Competent Cells Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Competent Cells Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Competent Cells Market Type Movement Analysis
  • 4.3. Global Competent Cells Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Chemically Competent Cells
    • 4.4.1. Chemically competent cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Electrocompetent Cells
    • 4.5.1. Electrocompetent cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Ultracompetent Cells
    • 4.6.1. Ultracompetent cells market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Competent Cells Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Competent Cells Market Application Movement Analysis
  • 5.3. Global Competent Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cloning
    • 5.4.1. Cloning market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Protein Expression
    • 5.5.1. Protein expression market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Mutagenesis
    • 5.6.1. Mutagenesis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competent Cells Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Competent Cells Market End-use Movement Analysis
  • 6.3. Global Competent Cells Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competent Cells Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive scenario
      • 7.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive scenario
      • 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Agilent Technologies, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Takara Bio Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. New England Biolabs (UK) Ltd.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Promega Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Bio-Rad Laboratories
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Roche Applied Science
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Qiagen
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. SGI-DNA (Synthetic Genomics, Inc.)
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global competent cells market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Mexico competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 UK competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 France competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 30 France competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 31 France competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Denmark competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Sweden competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Norway competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 China competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 52 China competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 53 China competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Japan competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 India competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 58 India competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 59 India competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 South Korea competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Australia competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Thailand competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Latin America competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Brazil competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 MEA competent cells market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 South Africa competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 UAE competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE competent cells market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait competent cells market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait competent cells market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait competent cells market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Competent cells market: Market outlook
  • Fig. 5 Competent cells market: Segment outlook
  • Fig. 6 Competent cells market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Competent cells market driver impact
  • Fig. 9 Competent cells market restraint impact
  • Fig. 10 Competent cells market: Type outlook and key takeaways
  • Fig. 11 Competent cells market: Type movement analysis
  • Fig. 12 Chemically competent cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Electrocompetent cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Ultracompetent cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Competent cells market: Application outlook and key takeaways
  • Fig. 16 Competent cells market: Application movement analysis
  • Fig. 17 Cloning market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Mutagenesis market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 Competent cells market: End-use outlook and key takeaways
  • Fig. 22 Competent cells market: End-use movement analysis
  • Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global competent cells market: Regional outlook and key takeaways
  • Fig. 27 Global competent cells market: Regional movement analysis
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)